

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.54653611 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.54653611 |
| 3 | exogenous drug catabolic process (GO:0042738) | 7.23860731 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.19880274 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.19880274 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.76295936 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.68350812 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.40867024 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 6.27028699 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.08589910 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.08589910 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.08589910 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.99521631 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.94697653 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.82792127 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.75473218 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.73841990 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.69092622 |
| 19 | urea cycle (GO:0000050) | 5.68828443 |
| 20 | urea metabolic process (GO:0019627) | 5.68828443 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.66386824 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53893782 |
| 23 | regulation of plasminogen activation (GO:0010755) | 5.52224168 |
| 24 | protein carboxylation (GO:0018214) | 5.45179221 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45179221 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.44021095 |
| 27 | * regulation of protein activation cascade (GO:2000257) | 5.35483036 |
| 28 | cysteine metabolic process (GO:0006534) | 5.33618928 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.25817161 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.23612574 |
| 31 | drug metabolic process (GO:0017144) | 5.17222093 |
| 32 | bile acid metabolic process (GO:0008206) | 5.06631086 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.03399416 |
| 34 | oxidative demethylation (GO:0070989) | 5.02612731 |
| 35 | reverse cholesterol transport (GO:0043691) | 5.00684634 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.97627815 |
| 37 | phenylpropanoid metabolic process (GO:0009698) | 4.96804769 |
| 38 | * regulation of complement activation (GO:0030449) | 4.94007296 |
| 39 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.93579370 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.89929724 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.89277084 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.89277084 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.89277084 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.88362152 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84781787 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.78183486 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.77081804 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.66476550 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.66476550 |
| 50 | phospholipid efflux (GO:0033700) | 4.66465536 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.64567086 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.64567086 |
| 53 | * negative regulation of hemostasis (GO:1900047) | 4.63244885 |
| 54 | * negative regulation of blood coagulation (GO:0030195) | 4.63244885 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.60170902 |
| 56 | lysine metabolic process (GO:0006553) | 4.51404003 |
| 57 | lysine catabolic process (GO:0006554) | 4.51404003 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.49619565 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.46994064 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.35269054 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.34355080 |
| 62 | cholesterol efflux (GO:0033344) | 4.32942371 |
| 63 | glycine metabolic process (GO:0006544) | 4.30730391 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.30498546 |
| 65 | coenzyme catabolic process (GO:0009109) | 4.30163975 |
| 66 | glutamate metabolic process (GO:0006536) | 4.27360931 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.24833159 |
| 68 | * negative regulation of coagulation (GO:0050819) | 4.23428565 |
| 69 | amine catabolic process (GO:0009310) | 4.23086401 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 4.23086401 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.23026126 |
| 72 | positive regulation of blood coagulation (GO:0030194) | 4.22749695 |
| 73 | positive regulation of hemostasis (GO:1900048) | 4.22749695 |
| 74 | intestinal cholesterol absorption (GO:0030299) | 4.21718326 |
| 75 | * negative regulation of wound healing (GO:0061045) | 4.17974337 |
| 76 | fibrinolysis (GO:0042730) | 4.17861601 |
| 77 | ethanol metabolic process (GO:0006067) | 4.17423905 |
| 78 | regulation of lipoprotein particle clearance (GO:0010984) | 4.13393016 |
| 79 | cellular glucuronidation (GO:0052695) | 4.11319061 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.10422824 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 4.10042291 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 4.09862544 |
| 83 | arginine metabolic process (GO:0006525) | 4.08195713 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06806869 |
| 85 | protein-lipid complex subunit organization (GO:0071825) | 4.06644949 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05679267 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 4.05085889 |
| 88 | * regulation of humoral immune response (GO:0002920) | 4.02834121 |
| 89 | blood coagulation, intrinsic pathway (GO:0007597) | 3.99785759 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 3.96223670 |
| 91 | ethanol oxidation (GO:0006069) | 3.94536194 |
| 92 | alkaloid metabolic process (GO:0009820) | 3.92000857 |
| 93 | aldehyde catabolic process (GO:0046185) | 3.91037701 |
| 94 | positive regulation of coagulation (GO:0050820) | 3.90512201 |
| 95 | drug catabolic process (GO:0042737) | 3.88580771 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.83948365 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81356196 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81356196 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.79185783 |
| 100 | protein activation cascade (GO:0072376) | 3.79039648 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.78995117 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 3.77413470 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76894165 |
| 104 | cofactor catabolic process (GO:0051187) | 3.76884646 |
| 105 | ketone body metabolic process (GO:1902224) | 3.76312469 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.76289845 |
| 107 | complement activation (GO:0006956) | 3.75918534 |
| 108 | S-adenosylmethionine metabolic process (GO:0046500) | 3.72400026 |
| 109 | cytolysis (GO:0019835) | 3.71454976 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.70587033 |
| 111 | heme transport (GO:0015886) | 3.70381624 |
| 112 | sterol homeostasis (GO:0055092) | 3.69541904 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.68740056 |
| 114 | organic acid catabolic process (GO:0016054) | 3.68740056 |
| 115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.67313981 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66190493 |
| 117 | protein-lipid complex assembly (GO:0065005) | 3.65743207 |
| 118 | glucuronate metabolic process (GO:0019585) | 3.64116567 |
| 119 | uronic acid metabolic process (GO:0006063) | 3.64116567 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.63521640 |
| 121 | hormone catabolic process (GO:0042447) | 3.62211147 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.60125413 |
| 123 | negative regulation of protein activation cascade (GO:2000258) | 3.60070008 |
| 124 | acute-phase response (GO:0006953) | 3.58930927 |
| 125 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.56417475 |
| 126 | acute inflammatory response (GO:0002526) | 3.47120118 |
| 127 | lipoprotein metabolic process (GO:0042157) | 3.44473358 |
| 128 | negative regulation of lipid transport (GO:0032369) | 3.42527143 |
| 129 | flavonoid metabolic process (GO:0009812) | 3.42287720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.27895366 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.05677337 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.91416290 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42928896 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.26984510 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.03880079 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.68307687 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02219674 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.78747354 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03816080 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9029666 |
| 12 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88599049 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85652264 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66276724 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57860229 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57190746 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40796928 |
| 18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38946360 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31698366 |
| 20 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17098215 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12060797 |
| 22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09322517 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00756926 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00554981 |
| 25 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99347096 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97800544 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96631087 |
| 28 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95107105 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93499203 |
| 30 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89652593 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88421040 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86547674 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86428614 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85670885 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81525315 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75604210 |
| 37 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75096690 |
| 38 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74427503 |
| 39 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72643437 |
| 40 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71883625 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71816200 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71816200 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71627256 |
| 44 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71009311 |
| 45 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70858231 |
| 46 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70585735 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70525990 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.68904863 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68824948 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.68056762 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.67937355 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67311314 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66696884 |
| 54 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66297769 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64966660 |
| 56 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.64722836 |
| 57 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.64217567 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64093840 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.63828910 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.63341389 |
| 61 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.62185830 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.61962962 |
| 63 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60690063 |
| 64 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58699333 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58635891 |
| 66 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.58564725 |
| 67 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.58276518 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57651674 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57460873 |
| 70 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57158489 |
| 71 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.56327091 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55701364 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.55144131 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54439393 |
| 75 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54438860 |
| 76 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.54241663 |
| 77 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54180541 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.53967050 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53547605 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.53454536 |
| 81 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.53224652 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.52968522 |
| 83 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52295423 |
| 84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.52193849 |
| 85 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.51234027 |
| 86 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50448221 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50200808 |
| 88 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49875449 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.49575707 |
| 90 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49350358 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.48759621 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.48701013 |
| 93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.48420074 |
| 94 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.48123343 |
| 95 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47958041 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.47817422 |
| 97 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.47812976 |
| 98 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47463018 |
| 99 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.47250616 |
| 100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.46944881 |
| 101 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.46859637 |
| 102 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46600982 |
| 103 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.46410986 |
| 104 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.46346497 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.45938319 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.45818163 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45778167 |
| 108 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45508882 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44759067 |
| 110 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.44088742 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44023165 |
| 112 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43381251 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43351796 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42882244 |
| 115 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42830129 |
| 116 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42506569 |
| 117 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41339125 |
| 118 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40748980 |
| 119 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.40690522 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40456580 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39322041 |
| 122 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37501680 |
| 123 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.37451052 |
| 124 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36711927 |
| 125 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35650568 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35073058 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34272003 |
| 128 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.34079226 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34047157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.20486739 |
| 2 | MP0005360_urolithiasis | 7.47279336 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.51668226 |
| 4 | MP0005365_abnormal_bile_salt | 6.26440614 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02676696 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.16163892 |
| 7 | MP0003252_abnormal_bile_duct | 3.89308665 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.63871383 |
| 9 | MP0009840_abnormal_foam_cell | 3.28554170 |
| 10 | MP0005083_abnormal_biliary_tract | 3.20893606 |
| 11 | MP0003195_calcinosis | 2.77994520 |
| 12 | MP0005332_abnormal_amino_acid | 2.74960879 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.67048669 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.31711262 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.16605392 |
| 16 | MP0000609_abnormal_liver_physiology | 2.12513326 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09129776 |
| 18 | MP0003868_abnormal_feces_composition | 1.99179627 |
| 19 | MP0003011_delayed_dark_adaptation | 1.96127288 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.95980385 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.77702933 |
| 22 | MP0001764_abnormal_homeostasis | 1.77248082 |
| 23 | MP0009697_abnormal_copulation | 1.66777209 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52573978 |
| 25 | MP0005451_abnormal_body_composition | 1.30643657 |
| 26 | MP0010368_abnormal_lymphatic_system | 1.24780398 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.19342213 |
| 28 | MP0003186_abnormal_redox_activity | 1.19118009 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.18096237 |
| 30 | MP0000598_abnormal_liver_morphology | 1.15555833 |
| 31 | MP0005647_abnormal_sex_gland | 1.08563975 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.08381889 |
| 33 | MP0000604_amyloidosis | 1.05734662 |
| 34 | MP0009764_decreased_sensitivity_to | 1.04588231 |
| 35 | MP0002254_reproductive_system_inflammat | 1.02104210 |
| 36 | MP0009763_increased_sensitivity_to | 1.01087445 |
| 37 | MP0001915_intracranial_hemorrhage | 0.98533380 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 0.97805592 |
| 39 | MP0002132_abnormal_respiratory_system | 0.96080390 |
| 40 | MP0005058_abnormal_lysosome_morphology | 0.95885386 |
| 41 | MP0000566_synostosis | 0.94690012 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 0.89604824 |
| 43 | MP0005408_hypopigmentation | 0.88954221 |
| 44 | * MP0009642_abnormal_blood_homeostasis | 0.84407166 |
| 45 | MP0008469_abnormal_protein_level | 0.84004522 |
| 46 | MP0003879_abnormal_hair_cell | 0.79333910 |
| 47 | * MP0005376_homeostasis/metabolism_phenot | 0.78086230 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 0.77935035 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 0.75656945 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.75653349 |
| 51 | MP0009053_abnormal_anal_canal | 0.74559383 |
| 52 | MP0005670_abnormal_white_adipose | 0.72065421 |
| 53 | MP0004130_abnormal_muscle_cell | 0.71753383 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 0.71603968 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 0.69879412 |
| 56 | MP0003690_abnormal_glial_cell | 0.69645293 |
| 57 | MP0002876_abnormal_thyroid_physiology | 0.69082132 |
| 58 | MP0005187_abnormal_penis_morphology | 0.68666540 |
| 59 | MP0001661_extended_life_span | 0.68398093 |
| 60 | MP0002971_abnormal_brown_adipose | 0.67929284 |
| 61 | MP0005535_abnormal_body_temperature | 0.64818060 |
| 62 | MP0005266_abnormal_metabolism | 0.62836450 |
| 63 | MP0005334_abnormal_fat_pad | 0.61803752 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.60119138 |
| 65 | MP0003329_amyloid_beta_deposits | 0.59275003 |
| 66 | MP0004272_abnormal_basement_membrane | 0.58809596 |
| 67 | MP0002822_catalepsy | 0.57113265 |
| 68 | MP0005023_abnormal_wound_healing | 0.54404476 |
| 69 | MP0009384_cardiac_valve_regurgitation | 0.54304091 |
| 70 | MP0005448_abnormal_energy_balance | 0.53916483 |
| 71 | MP0002928_abnormal_bile_duct | 0.53731329 |
| 72 | MP0001756_abnormal_urination | 0.53033121 |
| 73 | MP0002282_abnormal_trachea_morphology | 0.52397890 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.50574464 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.49208847 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.47712864 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.46760549 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.45800185 |
| 79 | MP0005395_other_phenotype | 0.45754961 |
| 80 | MP0003122_maternal_imprinting | 0.45468159 |
| 81 | MP0008874_decreased_physiological_sensi | 0.43639012 |
| 82 | MP0008873_increased_physiological_sensi | 0.42910294 |
| 83 | MP0003075_altered_response_to | 0.42888571 |
| 84 | MP0003718_maternal_effect | 0.40102743 |
| 85 | MP0003724_increased_susceptibility_to | 0.39926052 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.39925704 |
| 87 | MP0002090_abnormal_vision | 0.39908995 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.39677172 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.38647965 |
| 90 | MP0003953_abnormal_hormone_level | 0.38405313 |
| 91 | MP0004883_abnormal_blood_vessel | 0.38252632 |
| 92 | MP0005166_decreased_susceptibility_to | 0.37286513 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.37071618 |
| 94 | MP0008872_abnormal_physiological_respon | 0.36524845 |
| 95 | MP0001324_abnormal_eye_pigmentation | 0.35831599 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.35570586 |
| 97 | MP0004381_abnormal_hair_follicle | 0.35308826 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.34866449 |
| 99 | * MP0005464_abnormal_platelet_physiology | 0.34592879 |
| 100 | MP0000249_abnormal_blood_vessel | 0.34496680 |
| 101 | MP0000579_abnormal_nail_morphology | 0.33797602 |
| 102 | MP0005248_abnormal_Harderian_gland | 0.33440452 |
| 103 | MP0001243_abnormal_dermal_layer | 0.32650179 |
| 104 | MP0003941_abnormal_skin_development | 0.32346737 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.32259729 |
| 106 | MP0000920_abnormal_myelination | 0.30459943 |
| 107 | MP0003632_abnormal_nervous_system | 0.29815003 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.29717337 |
| 109 | MP0009672_abnormal_birth_weight | 0.28700811 |
| 110 | MP0002168_other_aberrant_phenotype | 0.28620135 |
| 111 | MP0003436_decreased_susceptibility_to | 0.28088314 |
| 112 | MP0009115_abnormal_fat_cell | 0.27409958 |
| 113 | MP0002796_impaired_skin_barrier | 0.26255435 |
| 114 | MP0004147_increased_porphyrin_level | 0.24505820 |
| 115 | MP0003878_abnormal_ear_physiology | 0.24113005 |
| 116 | MP0005377_hearing/vestibular/ear_phenot | 0.24113005 |
| 117 | MP0002970_abnormal_white_adipose | 0.24109080 |
| 118 | MP0001881_abnormal_mammary_gland | 0.23628551 |
| 119 | MP0001853_heart_inflammation | 0.23476275 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.23030742 |
| 121 | MP0005409_darkened_coat_color | 0.22304510 |
| 122 | MP0000467_abnormal_esophagus_morphology | 0.22024297 |
| 123 | * MP0005164_abnormal_response_to | 0.21165783 |
| 124 | MP0009785_altered_susceptibility_to | 0.20864024 |
| 125 | MP0001944_abnormal_pancreas_morphology | 0.20753614 |
| 126 | MP0002128_abnormal_blood_circulation | 0.20345824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.59435473 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.34142627 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.31340196 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.76215609 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.63622055 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.38658647 |
| 7 | Xanthomatosis (HP:0000991) | 6.30804154 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.66853382 |
| 9 | Complement deficiency (HP:0004431) | 5.51793357 |
| 10 | Joint hemorrhage (HP:0005261) | 4.88573915 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.86443008 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.67702546 |
| 13 | Hyperammonemia (HP:0001987) | 4.55562229 |
| 14 | Epidermoid cyst (HP:0200040) | 4.47353871 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.45720563 |
| 16 | Hyperglycinemia (HP:0002154) | 4.36807475 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.32310575 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.24441700 |
| 19 | Ketosis (HP:0001946) | 4.21052501 |
| 20 | Fat malabsorption (HP:0002630) | 4.19232424 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18292391 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08350661 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.03333368 |
| 24 | Abnormality of complement system (HP:0005339) | 3.98678836 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.92681960 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85511342 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.84472701 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84472701 |
| 29 | Hyperglycinuria (HP:0003108) | 3.83355858 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79615820 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.71127329 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.62069724 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.35568887 |
| 34 | Spontaneous abortion (HP:0005268) | 3.26565789 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22492158 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.21368103 |
| 37 | Steatorrhea (HP:0002570) | 3.14654227 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.05681076 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.02516630 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.01589176 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 3.01331236 |
| 42 | Ketoacidosis (HP:0001993) | 2.96478164 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94693414 |
| 44 | Myocardial infarction (HP:0001658) | 2.92317805 |
| 45 | Osteomalacia (HP:0002749) | 2.84498981 |
| 46 | Skin nodule (HP:0200036) | 2.78669394 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.71731462 |
| 48 | Metabolic acidosis (HP:0001942) | 2.71573772 |
| 49 | Hypoglycemic seizures (HP:0002173) | 2.59810495 |
| 50 | Purpura (HP:0000979) | 2.58760650 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.56476456 |
| 52 | Lethargy (HP:0001254) | 2.56189167 |
| 53 | Acanthocytosis (HP:0001927) | 2.56094760 |
| 54 | Glomerulonephritis (HP:0000099) | 2.54289651 |
| 55 | Vascular calcification (HP:0004934) | 2.50822222 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48434807 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.48434807 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.47095111 |
| 59 | Abnormal gallbladder physiology (HP:0012438) | 2.45611781 |
| 60 | Cholecystitis (HP:0001082) | 2.45611781 |
| 61 | Cholelithiasis (HP:0001081) | 2.42387961 |
| 62 | Amyloidosis (HP:0011034) | 2.41374158 |
| 63 | Gout (HP:0001997) | 2.40448372 |
| 64 | Cerebral edema (HP:0002181) | 2.39835141 |
| 65 | Spastic diplegia (HP:0001264) | 2.38777674 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.37739973 |
| 67 | Mitral stenosis (HP:0001718) | 2.37411241 |
| 68 | Neonatal onset (HP:0003623) | 2.34367516 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33080100 |
| 70 | Esophageal varix (HP:0002040) | 2.31911865 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 2.30733871 |
| 72 | Arthropathy (HP:0003040) | 2.28777792 |
| 73 | Irritability (HP:0000737) | 2.28707958 |
| 74 | Gingival bleeding (HP:0000225) | 2.25761393 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.21402370 |
| 76 | Retinal atrophy (HP:0001105) | 2.19164412 |
| 77 | Malnutrition (HP:0004395) | 2.18089321 |
| 78 | Joint swelling (HP:0001386) | 2.17879172 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.16939392 |
| 80 | Pulmonary embolism (HP:0002204) | 2.16896607 |
| 81 | Menorrhagia (HP:0000132) | 2.13781757 |
| 82 | Thrombophlebitis (HP:0004418) | 2.12713392 |
| 83 | Pancreatitis (HP:0001733) | 2.11810433 |
| 84 | Glycosuria (HP:0003076) | 2.11228499 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 2.11228499 |
| 86 | Enlarged kidneys (HP:0000105) | 2.10791527 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09533163 |
| 88 | Poikilocytosis (HP:0004447) | 2.05130896 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.03986793 |
| 90 | Vomiting (HP:0002013) | 2.03473099 |
| 91 | Late onset (HP:0003584) | 2.02626680 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 2.00880761 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.00478201 |
| 94 | Fair hair (HP:0002286) | 2.00188439 |
| 95 | Brushfield spots (HP:0001088) | 1.99207384 |
| 96 | Abnormal delivery (HP:0001787) | 1.99040920 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.98444372 |
| 98 | Generalized aminoaciduria (HP:0002909) | 1.95006859 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94362698 |
| 100 | Rickets (HP:0002748) | 1.93132730 |
| 101 | Increased serum ferritin (HP:0003281) | 1.92814295 |
| 102 | Opisthotonus (HP:0002179) | 1.90392022 |
| 103 | Epistaxis (HP:0000421) | 1.90300206 |
| 104 | Elevated alkaline phosphatase (HP:0003155) | 1.89019925 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 1.88770724 |
| 106 | Status epilepticus (HP:0002133) | 1.87333128 |
| 107 | Nephritis (HP:0000123) | 1.85299853 |
| 108 | Pigmentary retinal degeneration (HP:0001146) | 1.84744942 |
| 109 | Bifid scrotum (HP:0000048) | 1.81478876 |
| 110 | Elevated hepatic transaminases (HP:0002910) | 1.80058819 |
| 111 | Abnormal cartilage morphology (HP:0002763) | 1.79440607 |
| 112 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78865715 |
| 113 | Alkalosis (HP:0001948) | 1.77835868 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.72952466 |
| 115 | Renal cortical cysts (HP:0000803) | 1.72344215 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.71680356 |
| 117 | Reticulocytosis (HP:0001923) | 1.71274866 |
| 118 | Hydroxyprolinuria (HP:0003080) | 1.69571595 |
| 119 | Abnormal urine phosphate concentration (HP:0012599) | 1.65891789 |
| 120 | Gangrene (HP:0100758) | 1.64922275 |
| 121 | Increased serum pyruvate (HP:0003542) | 1.64759503 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.63456764 |
| 123 | Proximal tubulopathy (HP:0000114) | 1.61286676 |
| 124 | Potter facies (HP:0002009) | 1.55205080 |
| 125 | Facial shape deformation (HP:0011334) | 1.55205080 |
| 126 | Back pain (HP:0003418) | 1.53847085 |
| 127 | Abnormal tarsal ossification (HP:0008369) | 1.52142418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.04418976 |
| 2 | FGFR4 | 4.44383099 |
| 3 | SIK1 | 4.35686949 |
| 4 | ERN1 | 4.27761399 |
| 5 | PDK2 | 4.02047845 |
| 6 | INSRR | 3.09069778 |
| 7 | TAOK3 | 2.95636522 |
| 8 | ERBB4 | 2.87940855 |
| 9 | MAP2K4 | 2.37609157 |
| 10 | NTRK3 | 2.06527028 |
| 11 | MST1R | 1.96528399 |
| 12 | PKN2 | 1.89455613 |
| 13 | MAPK11 | 1.89390137 |
| 14 | MUSK | 1.84110889 |
| 15 | DAPK2 | 1.75561594 |
| 16 | MAP3K12 | 1.72923387 |
| 17 | PIK3CG | 1.69452508 |
| 18 | FGFR2 | 1.60519742 |
| 19 | LATS1 | 1.60330141 |
| 20 | KDR | 1.57824712 |
| 21 | TYK2 | 1.57247890 |
| 22 | FLT3 | 1.56177160 |
| 23 | ABL2 | 1.53677193 |
| 24 | FRK | 1.51764221 |
| 25 | TESK2 | 1.51756894 |
| 26 | GRK1 | 1.48663226 |
| 27 | TRIB3 | 1.45336321 |
| 28 | PTK6 | 1.44687668 |
| 29 | TIE1 | 1.37600954 |
| 30 | LMTK2 | 1.31542164 |
| 31 | PRKAA2 | 1.29334295 |
| 32 | NEK9 | 1.27719382 |
| 33 | MAP3K2 | 1.27148003 |
| 34 | PINK1 | 1.23486608 |
| 35 | ERBB2 | 1.22958006 |
| 36 | JAK2 | 1.16453730 |
| 37 | MAP3K7 | 1.10424214 |
| 38 | EPHA2 | 1.09178048 |
| 39 | PRPF4B | 1.06739533 |
| 40 | PRKCZ | 1.01398609 |
| 41 | GRK6 | 1.00334269 |
| 42 | FGFR1 | 1.00043246 |
| 43 | MAP2K3 | 0.99766676 |
| 44 | MAPK12 | 0.99606786 |
| 45 | MAPK15 | 0.98493259 |
| 46 | MAPK4 | 0.95084941 |
| 47 | JAK1 | 0.90902857 |
| 48 | MAP3K10 | 0.90563562 |
| 49 | CAMK1D | 0.90003064 |
| 50 | MAP3K11 | 0.89629398 |
| 51 | TBK1 | 0.89446113 |
| 52 | PBK | 0.84318515 |
| 53 | MET | 0.82572266 |
| 54 | EPHA4 | 0.82312012 |
| 55 | MAPK7 | 0.79838755 |
| 56 | CAMK2G | 0.79453102 |
| 57 | EPHB2 | 0.78776208 |
| 58 | PRKG1 | 0.76400032 |
| 59 | IRAK3 | 0.76203041 |
| 60 | DYRK1B | 0.74336249 |
| 61 | * PRKACG | 0.72410731 |
| 62 | MAP3K3 | 0.72030956 |
| 63 | PRKAA1 | 0.69291088 |
| 64 | GSK3A | 0.68881785 |
| 65 | NLK | 0.68566346 |
| 66 | MAP3K14 | 0.68173333 |
| 67 | TGFBR2 | 0.67214090 |
| 68 | CDK6 | 0.64999455 |
| 69 | CDK12 | 0.64353788 |
| 70 | FER | 0.63432365 |
| 71 | ACVR1B | 0.62821233 |
| 72 | CAMK1G | 0.62567182 |
| 73 | EPHB1 | 0.62221330 |
| 74 | SGK3 | 0.61436867 |
| 75 | NUAK1 | 0.59051337 |
| 76 | RIPK1 | 0.57861540 |
| 77 | CSK | 0.57424259 |
| 78 | MAP2K1 | 0.56283062 |
| 79 | MAP2K6 | 0.56237535 |
| 80 | WNK3 | 0.55657487 |
| 81 | PTK2 | 0.55532096 |
| 82 | STK38L | 0.54689368 |
| 83 | PKN1 | 0.54556862 |
| 84 | PRKCQ | 0.54068166 |
| 85 | PAK3 | 0.53977392 |
| 86 | PDPK1 | 0.53334439 |
| 87 | * PRKACA | 0.53187267 |
| 88 | EPHA3 | 0.52868673 |
| 89 | CSNK1E | 0.52715322 |
| 90 | FGFR3 | 0.51500058 |
| 91 | MYLK | 0.50625319 |
| 92 | SCYL2 | 0.49976938 |
| 93 | RET | 0.48918894 |
| 94 | STK16 | 0.48380418 |
| 95 | SGK2 | 0.47236738 |
| 96 | SGK1 | 0.46462303 |
| 97 | IRAK2 | 0.46360108 |
| 98 | IGF1R | 0.46127956 |
| 99 | SRC | 0.45742174 |
| 100 | EIF2AK1 | 0.44738268 |
| 101 | CAMK4 | 0.43162084 |
| 102 | IKBKE | 0.43122914 |
| 103 | SGK223 | 0.41962041 |
| 104 | SGK494 | 0.41962041 |
| 105 | AKT3 | 0.40887497 |
| 106 | PDGFRA | 0.40848254 |
| 107 | CSNK1G1 | 0.40772777 |
| 108 | MAPKAPK3 | 0.40340575 |
| 109 | ZAP70 | 0.38886984 |
| 110 | AKT2 | 0.38671657 |
| 111 | CSF1R | 0.37563896 |
| 112 | ICK | 0.37338377 |
| 113 | STK38 | 0.36324859 |
| 114 | * PRKCB | 0.36171401 |
| 115 | MAP2K2 | 0.35126094 |
| 116 | WNK4 | 0.34546062 |
| 117 | EGFR | 0.34210022 |
| 118 | MTOR | 0.32892350 |
| 119 | MAP3K5 | 0.30647458 |
| 120 | MAP3K1 | 0.30054654 |
| 121 | CSNK1G2 | 0.29858935 |
| 122 | CSNK1A1 | 0.29465255 |
| 123 | RPS6KB1 | 0.29352622 |
| 124 | KSR2 | 0.29234740 |
| 125 | * CSNK2A1 | 0.29223515 |
| 126 | CDK9 | 0.29140615 |
| 127 | * PRKCA | 0.28880712 |
| 128 | CASK | 0.28237585 |
| 129 | KIT | 0.28183364 |
| 130 | * RPS6KA3 | 0.27165265 |
| 131 | PRKACB | 0.26956222 |
| 132 | CDK4 | 0.26774598 |
| 133 | MAP3K6 | 0.25675551 |
| 134 | PIK3CA | 0.25125863 |
| 135 | TAOK2 | 0.25054808 |
| 136 | PDK1 | 0.24245770 |
| 137 | IRAK1 | 0.24216847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.57606556 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.83830497 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46364767 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28347051 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.18327672 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84385791 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67480111 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65067409 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61506723 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57631101 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45669655 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34349265 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15598716 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11150390 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09402725 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.02892775 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92596675 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90397658 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89254523 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88804725 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87335203 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85715772 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78552313 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78218728 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74960327 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72201959 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70159341 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69657389 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64883544 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59595178 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56821841 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.54879245 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53980167 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53472206 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49971019 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48193110 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42680811 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32615363 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31661575 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29059573 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28310545 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.26938995 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26745560 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24450109 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19358566 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17067688 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16617250 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08723324 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08429731 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07650685 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03540279 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98477569 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96019628 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95548568 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94199998 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93065853 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91116987 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85086452 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79335943 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69488730 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68018240 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65944757 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62651453 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51888828 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51398127 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45001321 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44087959 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40227001 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39804691 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.37789352 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.28186019 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25220672 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22494847 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22296169 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22238363 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21706962 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20461274 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17370413 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16224640 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10846925 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07624872 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.04849933 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00798140 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.00642327 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2370633 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2295118 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2282273 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | -0.2251986 |
| 89 | Lysosome_Homo sapiens_hsa04142 | -0.2149969 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2085512 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | -0.2064474 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2017143 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1942030 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1881012 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1849694 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1684064 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1586575 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1494093 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1493692 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1470829 |
| 101 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1286474 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1200306 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1153437 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1023908 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0524740 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0378793 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0361068 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0301486 |

